NEW YORK, Aug. 24 (GenomeWeb News) - The US Food and Drug Administration will use Rosetta Biosoftware's Rosetta Resolver system for genomic data management and analysis in order to analyze microarray data from sponsors, Rosetta said today.

According to Rosetta, the Center for Drug Evaluation and Research, an arm of the FDA, will use the system when evaluating genomic data submitted through the voluntary genomic data submissions program the agency initiated this year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.